Application 1110
MRI for staging of rectal carcinoma
MRI for staging of rectal carcinoma
Application No. | 1110 |
| Application Name | MRI for staging of rectal carcinoma |
| Advisory Panel | Dr Michael Cleary (Chair and MSAC member) Dr David Gillespie (MSAC member) Dr Niall Tebbutt (Medical Oncology Group of Australia) Mr Brian Stafford (Consumer Health Forum Nominee) Dr K Chip Farmer (Royal Australasian College of Surgeons) Dr Jeremy Sharr (Royal Australian and New Zealand College of Radiologists) |
| Date Received by MSAC Secretariat | 12 September 2006 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | MSAC has considered the safety, effectiveness and cost-effectiveness of magnetic resonance imaging (MRI) for the initial staging, restaging and diagnosis of recurrence of rectal carcinoma in addition to conventional imaging. MSAC finds that MRI for the initial staging, restaging and diagnosis of recurrence of rectal carcinoma is safe. MSAC finds MRI for the initial staging of rectal cancer to be effective because MRI is able to define the circumferential resection margin of rectal carcinoma, which is highly predictive of the rate of local recurrence. MSAC finds that MRI for the initial staging of rectal carcinoma is likely to be cost-effective. MSAC recommends that public funding is supported for the initial staging of rectal carcinoma by MRI. There is insufficient evidence to support public funding for the restaging and diagnosis of recurrence of rectal carcinoma by MRI. |
| Stage 4 - Decision Noting of MSAC advice by the Minister does not constitute a final decision in relation to the provision of public funding. | MSAC considered this assessment on 6 June 2008. The Minister noted MSAC's advice on 28 August 2008. |
| Stage 5 - Implementation |  |
Page currency, Latest update: 03 April, 2009
